Saliva test as effective as blood tests in determining disease symptoms

Image
ANI Washington
Last Updated : Oct 30 2014 | 7:27 PM IST

Scientists have revealed that simple tests on human saliva would be capable of diagnosing diabetes and cancer at an early stage and perhaps other neurological disorders and autoimmune diseases.

The study has brought to light that saliva contained many of the same disease-revealing molecules that were contained in blood.

Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry has said that if they could analyze constituents in saliva that could mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer and they could utilize this knowledge for personalized medicine.

The UCLA scientists have identified more than 400 circular RNAs in human saliva that was the first discovery of circular RNA in saliva or any body fluid that included 327 forms that were previously unknown.

While most RNA molecules translate genetic code from DNA to make proteins, there were also classes called non-coding RNAs that do not.

Saliva has been carrying with it non-coding RNAs, microRNAs, piRNAs and circRNAs that were biomarkers for disease and health monitoring without this study scientists would have never known that non-coding RNAs, microRNAs, piRNAs and circRNAs existed in saliva.

Their overriding conclusion was that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists would be able to take saliva samples to analyze for a variety of diseases.

Wong had said that the research could lead to a new category of self-diagnostic devices.

The study was published online by the peer-reviewed journal Clinical Chemistry.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 30 2014 | 1:59 PM IST

Next Story